CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Salix Pharmaceuticals, Ltd. et al.

Explore the PTAB proceeding IPR2016-01386 filed by Mylan Pharmaceuticals Inc. et al. on 2016-07-08. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01386

Filing Date

2016-07-08

Accorded Filing Date

2016-07-08

Institution Decision Date

2016-11-30

Last Modified Date

2024-01-11

Proceeding Type

IPR

Termination Date

2016-11-30

Trial Status

Terminated

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12573081
Respondent Patent Number 8865688
Legal Expiration Date
2030-05-01 Active (3.4 yrs remaining)
Patent Term Adjustment (PTA) +211 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor William Forbes
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Terminated

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

20 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name McCarter & English, LLP / Salix Pharmaceuticals
Customer Number 75093
Address 265 Franklin St., Boston, MA, 02110, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
32470 Thomas Hoover +1 617-449-6500
46590 David Burns +1 617-449-6500
50306 Yu Lu +1 617-449-6500
50445 John Curran +1 617-449-6500
53624 Jonathan Sparks +1 617-449-6500
54689 Jeffrey Safran +1 302-984-6357
55450 Jill Mello +1 617-449-6500
56266 Maria Laccotripe Zacharakis +1 617-449-6500

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 4 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 2 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 2 U.S. Courts: 4
USPTO PTAB Trial 2016-07-11
IPR2016-01409

MycoNovo, Inc. et al. v. Salix Pharmaceuticals, Ltd. et al.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2015-12-08
IPR2016-00297

GeneriCo, LLC et al. v. SALIX PHARMACEUTICALS, LTD. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2017-03-27
1:17-cv-00329

Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-06-26
1:15-cv-00109

Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc.

Asserted Patent
Status: WVND
U.S. District Court 2015-01-08
1:15-cv-00027

Salix Pharmaceuticals Inc. v. Novel Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-18
1:14-cv-00213

Salix Pharmaceuticals Inc. v. G & W Laboratories, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

40
9

Trial Instituted Document Paper

2016-11-30 FILING PARTY: None
8

Patent Ownerยฟยฟยฟs Waiver of Preliminary Response Under C.F.R. ยฟยฟ 42.107(b) Paper

2016-10-12 FILING PARTY: None
2001

Exhibit 2001 Exhibits

2016-08-03 FILING PARTY: None
7

Patent Owner's Exhibit List Paper

2016-08-03 FILING PARTY: None
2004

Exhibit 2004 Exhibits

2016-08-03 FILING PARTY: None

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc